Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sreenivasa Chary"'
Autor:
Shubhadeep D Sinha, Ghanashyam Biswas, Bala Reddy Bheemareddy, Sreenivasa Chary, Pankaj Thakur, Minish Jain, Tanveer Maksud, Suraj Pawar, Koushik Chatterjee, Murali Krishna Voonna, Anil Goel, Krishna Chaitanya Puligundla, Kuntegowdanahalli Chinnagiriyappa Lakshmaiah, Leela Talluri, Ramya Vattipalli, Sheejith Kakkunnath
Publikováno v:
Cancer Informatics, Vol 22 (2023)
Objective: The aim of this study was to evaluate the post-marketing safety, tolerability, immunogenicity and efficacy of Bevacizumab (manufactured by Hetero Biopharma) in a broader population of patients with solid tumors. Patients And Methods: This
Externí odkaz:
https://doaj.org/article/25def5a4029d43afa85aaee5274c5cf2
Autor:
Shubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, Firdaus Fatima, Vamsi Krishna Bandi, Pankaj Thakur, Bala Reddy, Sreenivasa Chary, Leela Talluri, Ajay Gupta, Amit Ramchandra Kale, Anil Kumar Gupta, Ashok Kumar P, Diwakar Reddy, Younus Mohammed, Soma Shekar, Sudheer T, Vijay G. Goni, Vishnu Sharma, Vishwanath Yeligod
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-11 (2020)
Abstract Background Our study aimed to compare efficacy and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Limited) versus reference adalimumab (Humira®, Abbvie Inc.) in Indian patients with active rheumatoid arthritis (RA) concomitant
Externí odkaz:
https://doaj.org/article/21f01bf2c5dd48bf9ae9be73c7e2fd34
Autor:
Shubhadeep D. Sinha, Vamsi Krishna Bandi, Bala Reddy Bheemareddy, Pankaj Thakur, Sreenivasa Chary, Kalpana Mehta, Vikranth Reddy Pinnamareddy, Rajendra Pandey, Subhramanyam Sreepada, Santosh Durugkar
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-5 (2019)
Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
Externí odkaz:
https://doaj.org/article/c89a8c713e804c20a5bf1e6d8a455d79
Autor:
Shubhadeep D. Sinha, Vamsi Krishna Bandi, Bala Reddy Bheemareddy, Pankaj Thakur, Sreenivasa Chary, Kalpana Mehta, Vikranth Reddy Pinnamareddy, Rajendra Pandey, Subhramanyam Sreepada, Santosh Durugkar
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Darbepoetin alfa (DA-α) is a long-acting erythropoiesis-stimulating glycoprotein which has half-life three-fold longer than that of Erythropoietin alfa (EPO). The objective of this study was to compare the efficacy and safety of
Externí odkaz:
https://doaj.org/article/35af966d045948f0b9108d371d0d1c66
Autor:
Shubhadeep D. Sinha, Sridevi Perapogu, Sreenivasa Chary S., S. Ramesh, Jaimanti Bakshi, Ajit Singh, Abdul Khabeer Ahmed, B. Mohan Reddy, Muralidhar Panapakam, Leela Talluri, Ramya Vattipalli
Publikováno v:
Journal of Asthma. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26f81d3af591aa9c048c36c0e54b5bb3
https://doi.org/10.1080/02770903.2023.2209175
https://doi.org/10.1080/02770903.2023.2209175
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pankaj Thakur, Younus Mohammed, Vijay Goni, Anil Kumar Gupta, Ajay Gupta, Leela Talluri, Bala Reddy Bheema Reddy, Syamasis Bandyopadhyay, Amit Kale, Sreenivasa Chary, Diwakar Reddy, Vamsi Krishna Bandi, Sudheer T, Ashok Kumar P, Vishnu Sharma, Soma Shekar, Biswadip Ghosh, Vishwanath Yeligod, Firdaus Fatima, Shubhadeep Sinha
Publikováno v:
BMC Rheumatology, Vol 4, Iss 1, Pp 1-11 (2020)
BMC Rheumatology
BMC Rheumatology
Background Our study aimed to compare efficacy and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Limited) versus reference adalimumab (Humira®, Abbvie Inc.) in Indian patients with active rheumatoid arthritis (RA) concomitant on methot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45207bddd53fb9cfa6fd86ea7b250cda
http://link.springer.com/article/10.1186/s41927-020-00124-9
http://link.springer.com/article/10.1186/s41927-020-00124-9
Autor:
Pankaj Jain, Gautam S K, Srinivas V C. Reddy, Shubhadeep Sinha, Pankaj Thakur, Jagan M Mohan, Mohan Reddy, Sunil Naik, Sreenivasa Chary, Leela Talluri
Publikováno v:
Cureus
Background: Acotiamide is a novel prokinetic drug that acts by enhancing the release of acetylcholine and is used in the treatment of functional dyspepsia-postprandial distress syndrome (FD-PDS). Mosapride is indicated to FD-PDS as per the Rome III t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41e725133f297ab360e104ed8654214
https://doi.org/10.7759/cureus.18109
https://doi.org/10.7759/cureus.18109
Autor:
Vijaya B Gupta, Pradeep Saha, Pankaj Thakur, Sreenivasa Chary, Leela Talluri, Shubhadeep Sinha, Kaja A Ramaiah, Siquafa Z Khanum, Mohan Reddy, Kamal K Verma
Publikováno v:
Cureus
Background Depression is a leading cause of psychiatric morbidity in the modern world, and the introduction of selective serotonin reuptake inhibitors (SSRIs) is a revolution in the treatment of depression. Vilazodone, a novel SSRI and 5-HT1A partial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71f0d99b34e2a6740d2d86895136b8d
https://pubmed.ncbi.nlm.nih.gov/34513348
https://pubmed.ncbi.nlm.nih.gov/34513348
Autor:
Bala Reddy Bheema Reddy, Leela Talluri, Vamsi Krishna Bandi, Sreenivasa Chary, Pankaj Thakur, Shubhadeep Sinha, Sheejith Kakkunnath
Publikováno v:
Cureus
Background This post-marketing surveillance (PMS), observational, prospective, safety study evaluated the safety, tolerability, and long-term immunogenicity of prescribed usage of Darbepoetin alfa (DA-α, manufactured by Hetero Biopharma, Hyderabad,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b686f2338cab08c9b002639bff883d6f
https://pubmed.ncbi.nlm.nih.gov/34079677
https://pubmed.ncbi.nlm.nih.gov/34079677